A Single Dose PK Study of Oxycodone Hydrochloride Injection 2.5, 5, and 10mg in Chinese Patients With Cancer Pain or Post-operation Patients

Trial Profile

A Single Dose PK Study of Oxycodone Hydrochloride Injection 2.5, 5, and 10mg in Chinese Patients With Cancer Pain or Post-operation Patients

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Aug 2015

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Cancer pain; Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Mundipharma International
  • Most Recent Events

    • 27 Aug 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 25 Apr 2012 Primary endpoints added as reported by ClinicalTrials.gov.
    • 03 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top